Document:

orbc-ex104_1542.htm

Exhibit 10.4

Schedule identifying agreements substantially identical to the form of Indemnity Agreement constituting Exhibit 10.3 hereto entered into by ORBCOMM Inc. and each of the following persons:

Jerome B. Eisenberg

Didier Delepine

Marco Fuchs

Timothy Kelleher

John Major

Gary Ritondaro

Marc Eisenberg(1)

Robert G. Costantini

John J. Stolte, Jr.

Christian G. LeBrun

Craig Malone

Constantine Milcos

 

	
(1)
	
Marc Eisenberg has also entered into indemnification agreements in substantially the same form as Exhibit 10.3, in his capacity as director with the following subsidiaries of ORBCOMM Inc.: Satcom International Group Plc. and MITE Global Communications S.A. de C.V.orbc-ex107_1543.htm

Exhibit 10.7

ORBCOMM Inc.

Summary of Compensation of Non-Employee Directors1 and 
Non-Executive Chairman of the Board 
(as of January 1, 2016) 

	
1.
	
Annual Retainer Fees 

	
 
	
·
	
Non-Employee Directors*:  $40,000 in cash paid in quarterly installments. 

	
 
	
·
	
Non-Executive Chairman of the Board:  $50,000 in cash paid in quarterly installments. 

	
 
	
·
	
Deferrals:  Directors may elect to defer all or part of the cash payment of retainer fees until such time as specified, with interest on deferred amounts accruing quarterly at 120% of the Federal long-term rate set each month by the Secretary of the Treasury.

	
2.
	
Annual Committee Membership Fees (Non-Employee Directors only*)

	
 
	
·
	
Audit Committee: $5,000 ($15,000 for the Chairman).

	
 
	
·
	
Compensation Committee: $3,000 ($12,000 for the Chairman).

	
 
	
·
	
Nominating and Corporate Governance Committee: $3,000 ($10,000 for the Chairman).

	
 
	
·
	
Fees are paid in quarterly installments in cash.

	
 
	
·
	
Deferrals: Directors may elect to defer all or part of the cash payment of committee fees until such time as specified, with interest on deferred amounts accruing quarterly at 120% of the Federal long-term rate set each month by the Secretary of the Treasury.  

	
3.
	
Annual Awards 

	
 
	
·
	
Non-Employee Directors*/Non-Executive Chairman of the Board:  Time-based restricted stock units (RSUs) granted on or about January 2 of each year with a value of $80,000 based on the closing price of the Company’s common stock on Nasdaq on the date of grant and vesting on the immediately following January 1.  The RSUs will be granted to eligible directors under the Company’s 2006 Long-Term Incentives Plan.

	
	 

	
1
	
Other than Marco Fuchs, who does not receive annual retainer fees, committee membership fees or annual awards of RSUs.

CPAM: 1448656.5

 

	
 
	
·
	
Deferrals: Directors may elect to defer the vesting of all or part of the RSUs to a fixed date that is at least one year after the grant date. 

	
4.
	
Non-Executive Chairman of the Board Salary

	
 
	
·
	
Annual base salary of $53,750 (at-will employment)

2

CPAM: 1448656.5EX-10.31

 Exhibit 10.31 

Notice of Grant of Stock Option 
 and 

Terms and Conditions of Stock Option 
  

							
	Grantee:	 	[Name]	 	Option Number:	 	[                        ]
		 	[Address]	 	Plan:	 	2014
		 	[Address]	 	ID:	 	[                        ]

 Effective [                ]
(the “Award Date”), you (the “Grantee”) have been granted an incentive stock option (the “Option”) to buy [                ]
shares1 of Common Stock of Dicerna Pharmaceuticals, Inc. (the “Corporation”) at a price of
$[                ] per share1 (the “Exercise Price”). 

The aggregate Exercise Price of the shares subject to the Option is
$[                ].1 

[The Option will become vested as to 25% of the total number of shares of Common Stock subject to the Option on the first anniversary of the Award
Date. The remaining 75% of the total number of shares of Common Stock subject to the Option shall become vested in 36 substantially equal monthly installments, with the first installment vesting on the last day of the month following the month
in which the first anniversary of the Award Date occurs and an additional installment vesting on the last day of each of the 35 months thereafter.1,
2] [Modify as needed for vesting terms of the particular grant.]  

The Option will expire on [                ] (the
“Expiration Date”).1, 2 
 By your signature and the Corporation’s signature below, you
and the Corporation agree that the Option is granted under and governed by the terms and conditions of the Corporation’s 2014 Performance Incentive Plan (the “Plan”) and the Terms and Conditions of Incentive Stock Option (the
“Terms”), which are attached and incorporated herein by this reference. This Notice of Grant of Stock Option, together with the Terms, will be referred to as your Option Agreement. The Option has been granted to you in addition to, and not
in lieu of, any other form of compensation otherwise payable or to be paid to you. Capitalized terms are defined in the Plan if not defined herein or in the Terms. You acknowledge receipt of a copy of the Terms, the Plan and the Prospectus for the
Plan. 
  

					
	  
	 		 	  

	Dicerna Pharmaceuticals, Inc.	 		 	Date
			
	  
	 		 	  

	[Grantee Name]	 		 	Date

   

 

	1 	Subject to adjustment under Section 7.1 of the Plan. 

	2 	Subject to early termination under Section 5 of the Terms and Section 7.2 of the Plan. 

 DICERNA PHARMACEUTICALS, INC. 

2014 PERFORMANCE INCENTIVE PLAN 

TERMS AND CONDITIONS OF INCENTIVE STOCK OPTION 
  

	1.	General. 

 These Terms and Conditions of Incentive Stock Option (these
“Terms”) apply to a particular stock option (the “Option”) if incorporated by reference in the Notice of Grant of Stock Option (the “Grant Notice”) corresponding to that particular grant. The
recipient of the Option identified in the Grant Notice is referred to as the “Grantee.” The per share exercise price of the Option as set forth in the Grant Notice is referred to as the “Exercise Price.” The
effective date of grant of the Option as set forth in the Grant Notice is referred to as the “Award Date.” The exercise price and the number of shares covered by the Option are subject to adjustment under Section 7.1 of the Plan.

 The Option was granted under and subject to the Dicerna Pharmaceuticals, Inc. 2014 Performance Incentive Plan (the
“Plan”). Capitalized terms are defined in the Plan if not defined herein. The Option has been granted to the Grantee in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Grantee.
The Grant Notice and these Terms are collectively referred to as the “Option Agreement” applicable to the Option. 
  

	2.	Vesting; Limits on Exercise; Incentive Stock Option Status. 

 The Option shall
vest and become exercisable in percentage installments of the aggregate number of shares subject to the Option as set forth on the Grant Notice; provided, however, that the Option shall be subject to accelerated vesting as provided in Section 5.3
below in the event of the Grantee’s death or Total Disability (as defined in Section 5.3 below). The Option may be exercised only to the extent the Option is vested and exercisable. 

 

	 	•	 	Cumulative Exercisability. To the extent that the Option is vested and exercisable, the Grantee has the right to exercise the Option (to the extent not previously exercised), and such right shall continue,
until the expiration or earlier termination of the Option. 

  

	 	•	 	No Fractional Shares. Fractional share interests shall be disregarded, but may be cumulated. 

  

	 	•	 	Minimum Exercise. No fewer than 100 shares of Common Stock (subject to adjustment under Section 7.1 of the Plan) may be purchased at any one time, unless the number purchased is the total number at the time
exercisable under the Option. 

  

	 	•	 	ISO Status. The Option is intended as an incentive stock option within the meaning of Section 422 of the Code (an “ISO”). 

 

	 	•	 	ISO Value Limit. If the aggregate fair market value of the shares with respect to which ISOs (whether granted under the Option or otherwise) first become exercisable by the Grantee in any calendar year
exceeds $100,000, as measured on the applicable Award Dates, the limitations of Section 5.1.2 of the Plan shall apply and to such extent the Option will be rendered a nonqualified stock option. 

	3.	Continuance of Employment/Service Required; No Employment/Service Commitment. 

The vesting schedule applicable to the Option requires continued employment or service through each applicable vesting date as a condition to
the vesting of the applicable installment of the Option and the rights and benefits under this Option Agreement. Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Grantee to any
proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 5 below or under the Plan. 

Nothing contained in this Option Agreement or the Plan constitutes a continued employment or service commitment by the Corporation or any of
its Subsidiaries, affects the Grantee’s status, if he or she is an employee, as an employee at will who is subject to termination without cause, confers upon the Grantee any right to remain employed by or in service to the Corporation or any
Subsidiary, interferes in any way with the right of the Corporation or any Subsidiary at any time to terminate such employment or service, or affects the right of the Corporation or any Subsidiary to increase or decrease the Grantee’s other
compensation. Nothing in this Option Agreement, however, is intended to adversely affect any independent contractual right of the Grantee without his/her consent thereto. 
  

	4.	Method of Exercise of Option. 

 The Option shall be exercisable by the delivery to
the Secretary of the Corporation (or such other person as the Administrator may require pursuant to such administrative exercise procedures as the Administrator may implement from time to time) of: 

 

	 	•	 	a written notice stating the number of shares of Common Stock to be purchased pursuant to the Option or by the completion of such other administrative exercise procedures as the Administrator may require from time to
time, 

  

	 	•	 	payment in full for the Exercise Price of the shares to be purchased in cash, check or by electronic funds transfer to the Corporation; 

 

	 	•	 	any written statements or agreements required pursuant to Section 8.1 of the Plan; and 

  

	 	•	 	satisfaction of the tax withholding provisions of Section 8.5 of the Plan. 

 The Administrator
also may, but is not required to, authorize a non-cash payment alternative by one or more of the following methods (subject in each case to compliance with all applicable laws, rules, regulations and listing requirements and further subject to such
rules as the Administrator may adopt as to any such payment method): 
  

	 	•	 	notice and third party payment in such manner as may be authorized by the Administrator; 

	 	•	 	in shares of Common Stock already owned by the Grantee, valued at their fair market value (as determined under the Plan) on the exercise date; 

 

	 	•	 	a reduction in the number of shares of Common Stock otherwise deliverable to the Grantee (valued at their fair market value on the exercise date, as determined under the Plan) pursuant to the exercise of the Option; or

  

	 	•	 	a “cashless exercise” with a third party who provides simultaneous financing for the purposes of (or who otherwise facilitates) the exercise of the Option. 

The Option will qualify as an ISO only if it meets all of the applicable requirements of the Code. The Option may be rendered a
nonqualified stock option if the Administrator permits the use of one or more of the non-cash payment alternatives referenced above. 
  

	5.	Early Termination of Option. 

 5.1
Expiration Date. Subject to earlier termination as provided below in this Section 5, the Option will terminate on the “Expiration Date” set forth in the Grant Notice (the “Expiration Date”). 

5.2 Possible Termination of Option upon Certain Corporate Events. The Option is subject to termination in connection with
certain corporate events as provided in Section 7.2 of the Plan. 
 5.3 Termination of Option upon a Termination of Grantee’s
Employment or Services. Subject to earlier termination on the Expiration Date of the Option or pursuant to Section 5.2 above, if the Grantee ceases to be employed by or ceases to provide services to the Corporation or a Subsidiary, the following
rules shall apply (the last day that the Grantee is employed by or provides services to the Corporation or a Subsidiary is referred to as the Grantee’s “Severance Date”): 

 

	 	•	 	other than as expressly provided below in this Section 5.3, (a) the Grantee will have until the date that is 3 months after his or her Severance Date to exercise the Option (or portion thereof) to the extent that it was
vested on the Severance Date, (b) the Option, to the extent not vested on the Severance Date, shall terminate on the Severance Date, and (c) the Option, to the extent exercisable for the 3-month period following the Severance Date and not exercised
during such period, shall terminate at the close of business on the last day of the 3-month period; 

  

	 	•	 	 if the termination of the Grantee’s employment or services is the result of the Grantee’s death or Total Disability (as defined below), (a)
the Option shall accelerate and be vested and exercisable as of the Grantee’s Severance Date with respect to fifty percent (50%) of the then-outstanding and unvested portion of the Option, (b) any portion of the Option that is not vested after
giving effect to the foregoing clause (a) shall terminate on the Severance Date, (c) the Grantee (or his beneficiary or personal representative, as the case may be) will have until the date that is 12 months after the Grantee’s Severance Date
to exercise the vested portion of the Option, and (d) the 

	 	 
Option, to the extent exercisable for the 12-month period following the Severance Date and not exercised during such period, shall terminate at the close of business on the last day of the
12-month period; 

  

	 	•	 	if the Grantee’s employment or services are terminated by the Corporation or a Subsidiary for Cause (as defined below), the Option (whether vested or not) shall terminate on the Severance Date. 

For purposes of the Option, “Total Disability” means a “permanent and total disability” (within the meaning of
Section 22(e)(3) of the Code or as otherwise determined by the Administrator). 
 For purposes of the Option, “Cause” means
that the Grantee: 
  

	 	(1)	has been negligent in the discharge of his or her duties to the Corporation or any of its Subsidiaries, has refused to perform stated or assigned duties or is incompetent in or (other than by reason of a disability or
analogous condition) incapable of performing those duties; 

  

	 	(2)	has been dishonest or committed or engaged in an act of theft, embezzlement or fraud, a breach of confidentiality, an unauthorized disclosure or use of inside information, customer lists, trade secrets or other
confidential information; has breached a fiduciary duty, or willfully and materially violated any other duty, law, rule, regulation or policy of the Corporation, any of its Subsidiaries or any affiliate of the Corporation or any of its Subsidiaries;
or has been convicted of a felony or misdemeanor (other than minor traffic violations or similar offenses); 

  

	 	(3)	has materially breached any of the provisions of any agreement with the Corporation, any of its Subsidiaries or any affiliate of the Corporation or any of its Subsidiaries; or 

 

	 	(4)	has engaged in unfair competition with, or otherwise acted intentionally in a manner injurious to the reputation, business or assets of, the Corporation, any of its Subsidiaries or any affiliate of the Corporation or
any of its Subsidiaries; has improperly induced a vendor or customer to break or terminate any contract with the Corporation, any of its Subsidiaries or any affiliate of the Corporation or any of its Subsidiaries; or has induced a principal for whom
the Corporation, any of its Subsidiaries or any affiliate of the Corporation or any of its Subsidiaries acts as agent to terminate such agency relationship. 

In all events the Option is subject to earlier termination on the Expiration Date of the Option or as contemplated by Section 5.2. The
Administrator shall be the sole judge of whether the Grantee continues to render employment or services for purposes of this Option Agreement. 

Notwithstanding any post-termination exercise period provided for herein or in the Plan, the Option will qualify as an ISO only if it is
exercised within the applicable exercise periods for ISOs under, and meets all of the other requirements of, the Code. If the Option is not exercised within the applicable exercise periods for ISOs or does not meet such other requirements, the
Option will be rendered a nonqualified stock option. 

	6.	Non-Transferability. 

 The Option and any other rights of the Grantee under this
Option Agreement or the Plan are nontransferable and exercisable only by the Grantee, except as set forth in Section 5.7 of the Plan. 
  

	7.	Notices. 

 Any notice to be given under the terms of this Option Agreement shall
be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Grantee at the address last reflected on the Corporation’s payroll records, or at such other address as either party may
hereafter designate in writing to the other. Any such notice shall be delivered in person or shall be enclosed in a properly sealed envelope addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee
prepaid) in a post office or branch post office regularly maintained by the United States Government. Any such notice shall be given only when received, but if the Grantee is no longer employed by the Corporation or a Subsidiary, shall be deemed to
have been duly given five business days after the date mailed in accordance with the foregoing provisions of this Section 7. 
  

	8.	Plan. 

 The Option and all rights of the Grantee under this Option Agreement are
subject to the terms and conditions of the Plan, incorporated herein by this reference. The Grantee agrees to be bound by the terms of the Plan and this Option Agreement. The Grantee acknowledges having read and understanding the Plan, the
Prospectus for the Plan, and this Option Agreement. Unless otherwise expressly provided in other sections of this Option Agreement, provisions of the Plan that confer discretionary authority on the Board or the Administrator do not and shall
not be deemed to create any rights in the Grantee unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate action of the Board or the Administrator under
the Plan after the date hereof. 
  

	9.	Entire Agreement. 

 This Option Agreement and the Plan together constitute the
entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. The Plan and this Option Agreement may be amended pursuant to Section 8.6 of the
Plan. Such amendment must be in writing and signed by the Corporation. The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Grantee
hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof. 

	10.	Governing Law. 

 This Option Agreement shall be governed by and construed and
enforced in accordance with the laws of the State of Delaware without regard to conflict of law principles thereunder. 
  

	11.	Effect of this Agreement. 

 Subject to the Corporation’s right to terminate
the Option pursuant to Section 7.2 of the Plan, this Option Agreement shall be assumed by, be binding upon and inure to the benefit of any successor or successors to the Corporation. 

 

	12.	Counterparts. 

 This Option Agreement may be executed simultaneously in any number
of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.
  

	13.	Section Headings. 

 The section headings of this Option Agreement are for
convenience of reference only and shall not be deemed to alter or affect any provision hereof. 
  

	14.	Clawback Policy. 

 The Option is subject to the terms of the Corporation’s
recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require forfeiture of the Option and repayment or forfeiture of any
shares of Common Stock or other cash or property received with respect to the Option (including any value received from a disposition of the shares acquired upon exercise of the Option). 

 

	15.	No Advice Regarding Grant. 

 The Grantee is hereby advised to consult with his or
her own tax, legal and/or investment advisors with respect to any advice the Grantee may determine is needed or appropriate with respect to the Option (including, without limitation, to determine the foreign, state, local, estate and/or gift tax
consequences with respect to the Option and any shares that may be acquired upon exercise of the Option). Neither the Corporation nor any of its officers, directors, affiliates or advisors makes any representation (except for the terms and
conditions expressly set forth in this Option Agreement) or recommendation with respect to the Option. Except for the withholding rights contemplated by Section 4 above and Section 8.5 of the Plan, the Grantee is solely responsible for any and
all tax liability that may arise with respect to the Option and any shares that may be acquired upon exercise of the Option.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]